Corporate Controller at Freenome

Brisbane, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, HealthcareIndustries

Requirements

Hands-on experience managing accounting close processes with ability to drive efficiencies for a 5-day close
Expertise in reviewing and approving journal entries and account reconciliations, with strong SOX compliance knowledge
Ability to implement balance sheet, income statement, and cash flow analytics
Experience identifying and reviewing accounting implications of non-standard contracts and agreements
Proficiency in leading system implementations/upgrades (e.g., NetSuite) to build scalable processes
Capability to prepare/review schedules for external financial statements, footnotes, and MD&A (e.g., 10-Q, 10-K, S-1)
Experience preparing and presenting materials at board and audit committee meetings, managing audit committee charter
Knowledge of developing procure-to-pay processes, financial approval matrices, and workflows
Familiarity with Contract Lifecycle Management Systems
Oversight experience in T&E policies, corporate credit card programs, and expense management software
Treasury process management and coordination with external tax service providers
Collaboration skills for internal controls, SEC Reporting, and SOX compliance

Responsibilities

Lead and coordinate day-to-day activities of the accounting department
Manage accounting close process, driving continuous efficiencies for a 5-day close
Review and approve journal entries and account reconciliations; enhance SOX-compliant documentation
Implement balance sheet, income statement, and cash flow analytics for internal reporting
Identify and review accounting implications of non-standard contracts; document and implement technical accounting
Lead implementation/upgrade of systems (e.g., NetSuite) for scalable accounting close and reporting
Prepare/review schedules for external financial statements, footnotes, and MD&A
Prepare and present materials at board and audit committee meetings; manage audit committee charter
Develop and implement procure-to-pay processes; update financial approval matrix and workflows
Support implementation of a Contract Lifecycle Management System
Oversee compliance with T&E Policy and corporate credit card program; evaluate and implement expense management solutions
Oversee treasury processes and external tax service providers
Collaborate with Director, SEC Reporting/SOX Compliance on designing and operating effective financial controls

Skills

Accounting Close

Financial Reporting

SOX Compliance

Accounting Processes

GAAP

ERP Systems

Month-End Close

Audit Management

Freenome

Biotechnology company for early cancer detection

About Freenome

Freenome focuses on improving cancer detection through advanced blood tests. The company uses a multiomics approach, analyzing various biological data types, including genomics and proteomics, to find cancer markers in blood samples. This method allows for non-invasive early detection of cancer, which is crucial for effective treatment. Freenome differentiates itself from competitors by its unique combination of data analysis techniques and its commitment to clinical trials and research collaborations. The company's goal is to enhance cancer diagnostics and make early detection accessible to healthcare providers and patients, ultimately aiming to save lives through timely intervention.

San Francisco, CaliforniaHeadquarters

2014Year Founded

$1,032.6MTotal Funding

LATE_VCCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Competitive market-based salaries

Annual bonus opportunities

Relocation packages

Medical, dental, & vision coverage

401k

Wellness programs

Equity

PTO

Risks

Employee layoffs may affect morale and innovation efforts.

Integration of Oncimmune Ltd. could divert focus from core projects.

Competitive landscape in cancer detection may impact Freenome's market share.

Differentiation

Freenome uses a unique multiomics approach for early cancer detection.

The company focuses on non-invasive blood tests for cancer screening.

Freenome's platform designs personalized health conditions based on cell-free genome analysis.

Upsides

Recent $254 million funding boosts clinical programs and platform expansion.

Partnership with Walgreens enhances clinical trial diversity and patient recruitment.

PROACT LUNG study positions Freenome as a leader in lung cancer diagnostics.

Land your dream remote job 3x faster with AI

Try Jobo Free